Stephanie Gaillard

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    NRG
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Tempest
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Tesaro/GSK
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    UptoDate
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Verastem
    Date added:
    08/29/2023
    Date updated:
    08/29/2023

Pages

Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond